US$ 28.30
semaglutide biologic Popular GLP-1 drug may slow down biological aging, analysis indicates GLP-1s show signs of slowing
Description
Semaglutide is a weight loss injection that has been medically approved and is now being offered as an option at the biostation in Miami Florida

Monitoring Side Effects and When to Seek Help Semaglutide is generally well tolerated, but monitoring is essential

Pfizer U.S
Research Gaps and Future Directions in GLP-1, Cancer Studies Most clinical evidence pertains to cancer incidence rather than progression, and the review calls for additional trials specifically in patients undergoing cancer treatment or in remission